T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
Clinical trial NCT07581496 · RECRUITING
Trial details
- NCT number
- NCT07581496
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-18
- Primary completion
- 2030-06-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.